At a glance
ClinicalIndex Comparison RecordStandardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Assessment of Arformoterol for COPD Using Hyperpolarized 3He MRI
In Brief
A clinical study evaluating Hyperpolarized Helium-3, Placebo, and 1 other intervention for Chronic Obstructive Pulmonary Disease. Completed, enrolled 16 participants across 1 site.
Detailed Summary
The purpose of this study is to determine efficacy of MR imaging with hyperpolarized helium-3 gas in COPD patients both before and after treatment.
Study Details
Timeline
Interventions
Patients will be required to breath in individual 1 liter bags of gas while in an MRI to produce lung images. These bags of gas are each made up of 333mL of Helium-3 gas and 667mL of Nitrogen. The first three bags will be administered with a break between each of five to ten minutes. Then the intervention (drug or placebo) will be administered and an hour will pass. Then three additional bags will be administered, again with five to ten minutes between each bag.
Subject will inhale a placebo (nebulized saline) with no drug.
Subjects will receive the drug arformoterol prior to scanning